Ivermectin Tablets 12mg
Recent News
A Pennsylvania doctor accused of prescribing ivermectin and hydroxychloroquine to treat Covid-19, two drugs that regulators have called not safe for treating the disease, was fired this week, a regional health system said.
“We investigated the matter and, as a result, Dr. Behr’s employment with Tower Health Medical Group has been terminated effective immediately,” the health system said in a statement on Friday.
After a brief investigation, a Pennsylvania health group terminated the employment of a doctor said to have prescribed ivermectin to treat Covid-19.
Ivermectin Pills for Sale
The doctor, Edith Behr, who worked for Tower Health, was accused of writing prescriptions for the drugs, which are not approved for the prevention or treatment of Covid, the company said. The health system said it became aware of the allegations against Dr. Behr on Wednesday.
Ivermectin, used to treat infections caused by parasitic worms as well as head lice, rosacea and scabies, is one of the medications being tested as a treatment for COVID-19 by the National Institute of Health’s Accelerating COVID-19 Therapeutic Intervention and Vaccines public-private partnership. The University of South Florida and Tampa General Hospital are running the Tampa Bay study group.
The University of South Florida and Tampa General Hospital are participating in the National Institute of Health’s Accelerating COVID-19 Therapeutic Intervention and Vaccines public-private partnership, which brings together organizations and companies to study new COVID-19 treatments and variants. Launched last summer, the ACTIV-6 study looks at how three repurposed drugs respond to the virus:
Tampa General’s emergency room associate medical director, Jason Wilson, leads the USF Health/Tampa General study site. When an individual in Tampa Bay enrolls in the study online, a member of his team verifies their eligibility: They’re 30 or older, they’ve tested positive for COVID-19 within the past 10 days, and they’re experiencing at least two symptoms for seven days or less.
The double-blind study — meaning neither the researchers nor the subjects know whether they’re using one of the drugs or the placebo — expects to enroll 15,000 participants nationwide. Wilson said he expects about 100 participants in Tampa Bay.